[The neuropediatrician and the pediatric neurological emergencies]

J J García-Peñas1, R Muñoz-Orduña

  • 1Sección de Neurología Pediátrica, Hospital Infantil Universitario Niño Jesús, Madrid, España. jgarciape.hnjs@salud.madrid.org

Revista De Neurologia
|September 17, 2008
PubMed

Insights

Pediatric neurological emergencies, including acute paroxysmal episodes and headaches, are common in emergency departments. Understanding these frequencies helps improve care for these critical pediatric conditions.

Area of Science:

  • Pediatric Neurology
  • Emergency Medicine
  • Clinical Epidemiology

Context:

  • Neurological emergencies represent a significant proportion of pediatric emergency department visits.
  • Optimizing care requires understanding the spectrum and frequency of these conditions.
  • This study analyzes one year of data from a pediatric tertiary hospital.

Purpose:

  • To determine the actual incidence of pediatric neurological emergencies.
  • To identify the most common causes and diagnoses of pediatric neurological emergencies.
  • To inform the development of targeted clinical guidelines.

Summary:

  • Neurological conditions accounted for 1,760 of 93,469 emergency visits (1.9%).
  • Common presentations included acute paroxysmal episodes (48%) and headaches (41%).
  • Headache (39%), non-epileptic paroxysmal episodes (20%), and epileptic seizures (15%) were leading diagnoses. Only 17% required admission, primarily for epilepsy (41%).

Impact:

  • Neurological emergencies constitute a substantial portion of pediatric emergency care.
  • Four conditions—headaches, non-epileptic paroxysmal episodes, epileptic seizures, and febrile convulsions—account for nearly 85% of neurological emergencies.
  • Guidelines for pediatric neurological emergencies should focus on these prevalent conditions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...